Esophagitis dissecans superficialis associated with bisphosphonates.
Hokama
A
A
First Department of Internal Medicine, University of the Ryukyus, Okinawa, Japan. hokama-a@med.u-ryukyu.ac.jp
Ihama
Y
Y
Nakamoto
M
M
Kinjo
N
N
Kinjo
F
F
Fujita
J
J
D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D004941:Esophagitis / Q000139:chemically induced* / Q000175:diagnosis; D004945:Esophagoscopy; D004947:Esophagus / Q000187:drug effects / Q000473:pathology; D005260:Female; D006396:Hematemesis / Q000139:chemically induced*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D009092:Mucous Membrane / Q000187:drug effects / Q000473:pathology; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control
D000305:Adrenal Cortex Hormones; D004164:Diphosphonates